-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
NewAmsterdam Pharma Co N.V. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2021 to Q3 2025.
- NewAmsterdam Pharma Co N.V. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $15M, a 87.7% increase year-over-year.
- NewAmsterdam Pharma Co N.V. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $54.8M, a 81.5% increase year-over-year.
- NewAmsterdam Pharma Co N.V. annual Share-based Payment Arrangement, Expense for 2024 was $33.6M, a 36.8% increase from 2023.
- NewAmsterdam Pharma Co N.V. annual Share-based Payment Arrangement, Expense for 2023 was $24.6M, a 488% increase from 2022.
- NewAmsterdam Pharma Co N.V. annual Share-based Payment Arrangement, Expense for 2022 was $4.18M, a 245% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)